Additional multi-omics studies confirm that the HCC subtype with the lowest metabolic alteration level (mHCC2) displays robust CD8+ T cell infiltration and the best outcome, whereas the highly reprogrammed mHCC1 subtype is strongly immunosuppressed [47]. The gene discussed is CD8A; the disease is hepatocellular carcinoma.